Physician profile
David D Wright
NPI 1699745638
$47,485.43
in general payments reported to CMS, 2019-2025
91 companies · $4,795 in 2025
The $4,795 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $1,296 · 2021: $4,473 · 2022: $9,484 · 2023: $4,318 · 2024: $4,692 · 2025: $4,795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $5.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,800.24 |
| Education | $5.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $13,862.97 | 2019-2025 | Reblozyl, Pomalyst |
| Astrazeneca Pharmaceuticals Lp | $10,210.84 | 2019-2025 | Imfinzi, Enhertu, Datroway |
| E.R. Squibb & Sons, L.L.C. | $3,584.10 | 2019-2025 | Opdivo, Opdualag, Eliquis |
| Novartis Pharmaceuticals Corporation | $1,908.50 | 2019-2025 | |
| Janssen Biotech, INC. | $1,428.19 | 2019-2025 | Darzalex, Erleada, Rybrevant |
| Epizyme, INC. | $1,267.84 | 2021 | |
| Pfizer INC. | $1,182.94 | 2019-2025 | |
| Gilead Sciences, INC. | $1,032.96 | 2019-2025 | Trodelvy |
| Lilly USA, LLC | $888.55 | 2020-2025 | Verzenio, Jaypirca, Retevmo |
| Merck Sharp & Dohme LLC | $793.83 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Incyte Corporation | $793.33 | 2019-2025 | Jakafi, Monjuvi, Jakafi |
| Eisai INC. | $691.00 | 2019-2025 | |
| Genzyme Corporation | $649.39 | 2019-2025 | |
| Amgen INC. | $527.68 | 2019-2025 | Nplate, Vectibix, Vectibix |
| Tersera Therapeutics LLC | $514.97 | 2023-2025 | Zoladex |
Show all 85 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $492.09 | 2019-2025 | Polivy, Tecentriq, Alecensa |
| Exelixis INC. | $485.21 | 2019-2025 | Cabometyx |
| Seagen INC. | $457.81 | 2019-2023 | Tukysa, Padcev, Tivdak |
| Regeneron Healthcare Solutions, INC. | $438.31 | 2022-2025 | Libtayo |
| Daiichi Sankyo INC. | $434.67 | 2021-2025 | Enhertu, Datroway |
| Glaxosmithkline, LLC. | $368.32 | 2019-2025 | Ojjaara, Jemperli, Zejula |
| Abbvie INC. | $325.77 | 2019-2025 | Venclexta |
| Pharmacyclics LLC, An Abbvie Company | $319.12 | 2019-2023 | Imbruvica, Epkinly |
| Bayer Healthcare Pharmaceuticals INC. | $291.93 | 2019-2025 | |
| Astellas Pharma US INC | $260.17 | 2019-2025 | Padcev, Xospata, Vyloy |
| Puma Biotechnology, INC. | $215.45 | 2020-2025 | |
| Rigel Pharmaceuticals, INC. | $203.96 | 2023-2024 | Rezlidhia, Tavalisse |
| Deciphera Pharmaceuticals INC. | $200.46 | 2021-2025 | Qinlock, Romvimza |
| Beigene USA, INC. | $193.59 | 2022-2024 | Brukinsa |
| Takeda Pharmaceuticals U.S.A., INC. | $190.87 | 2019-2025 | Fruzaqla, Alunbrig |
| Athenex Pharmaceutical Division, LLC | $175.00 | 2020 | |
| Mirati Therapeutics, INC. | $154.18 | 2023-2024 | Krazati |
| Blueprint Medicines Corporation | $153.02 | 2020-2025 | Ayvakit |
| Dendreon Pharmaceuticals LLC | $152.48 | 2023-2025 | Provenge |
| Karyopharm Therapeutics INC. | $143.63 | 2022-2025 | Xpovio |
| Aveo Pharmaceuticals, INC. | $137.29 | 2022-2025 | Fotivda |
| Sumitomo Pharma America, INC. | $136.44 | 2023-2025 | Orgovyx |
| Pharmaessentia USA Corporation | $134.65 | 2024-2025 | Besremi |
| Kite Pharma, INC. | $125.90 | 2020-2025 | Yescarta |
| Jazz Pharmaceuticals INC. | $120.06 | 2020-2025 | |
| Ipsen Biopharmaceuticals, INC | $119.32 | 2019-2024 | Onivyde, Somatuline Depot |
| Tetraphase Pharmaceuticals, INC. | $105.89 | 2019-2020 | |
| Tempus Ai, INC | $95.08 | 2024 | Xt Cdx |
| Array Biopharma INC | $90.06 | 2020-2025 | Mektovi, Braftovi, Lorbrena |
| Taiho Oncology, INC. | $86.33 | 2022-2025 | |
| Geron Corporation | $83.98 | 2024-2025 | Rytelo |
| Legend Biotech USA INC. | $82.77 | 2024-2025 | Carvykti |
| Stemline Therapeutics INC. | $81.77 | 2023-2025 | Orserdu |
| Emd Serono, INC. | $80.72 | 2019-2025 | |
| Sobi, INC | $79.58 | 2022-2024 | |
| Genmab U.S., INC. | $66.89 | 2023-2025 | Epkinly |
| Alexion Pharmaceuticals, INC. | $66.81 | 2019-2025 | Ultomiris |
| Springworks Therapeutics, INC. | $55.03 | 2024 | Ogsiveo |
| Myriad Genetic Laboratories, INC. | $51.69 | 2024 | Myrisk |
| Aadi Bioscience, INC. | $47.37 | 2024 | Fyarro |
| Cti Biopharma Corp. | $44.69 | 2023 | Vonjo |
| Clovis Oncology, INC. | $38.58 | 2019 | |
| Pharmacosmos Therapeutics INC. | $38.06 | 2023-2024 | Cosela, Monoferric |
| Ge Healthcare | $36.37 | 2022 | |
| Medtronic, INC. | $35.50 | 2021-2022 | |
| Agios Pharmaceuticals, INC. | $34.14 | 2023-2025 | Pyrukynd |
| Argenx US, INC. | $32.41 | 2025 | Vyvgart Hytrulo, Vyvgart |
| Tesaro, INC. | $30.42 | 2019 | |
| Telix Pharmaceuticals | $24.57 | 2023 | Illuccix |
| Servier Pharmaceuticals LLC | $24.56 | 2023 | |
| Syndax Pharmaceuticals, INC. | $21.86 | 2025 | |
| Alnylam Pharmaceuticals INC. | $21.37 | 2022 | |
| Csl Behring | $20.28 | 2022 | |
| Apellis Pharmaceuticals, INC. | $19.96 | 2023 | Empaveli |
| G1 Therapeutics, INC. | $19.14 | 2022 | |
| Adc Therapeutics America, INC. | $17.84 | 2023 | |
| Kyowa Kirin, INC. | $16.37 | 2024 | Poteligeo |
| Sirtex Medical INC | $16.27 | 2020-2024 | Sir-Spheres Microspheres |
| Morphosys, US INC. | $16.04 | 2023 | Monjuvi |
| Myovant Sciences INC. | $15.74 | 2022 | |
| Foundation Medicine, INC. | $14.52 | 2023 | |
| Shield Therapeutics INC | $14.21 | 2024 | |
| Beone Medicines USA, INC. | $14.12 | 2025 | Brukinsa |
| Dova Pharmaceuticals | $13.73 | 2020 | |
| Acrotech Biopharma INC. | $13.72 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $13.37 | 2019 | |
| Aurobindo Pharma USA, INC. | $13.11 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.08 | 2019 | |
| Secura Bio, INC. | $10.11 | 2022 | |
| Veracyte, INC. | $1.53 | 2020 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,446.88 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.